Sven C. Hagemann
Halle, NI 06120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Insights into the Design of MYC-Targeting Proteolysis Targeting Chimeras (PROTACs).
Journal: Molecules (Basel, Switzerland)
Published: January 23, 2026
RNA-seq-derived sequence variations are excellent features for cell line identification.
Journal: Computational and structural biotechnology journal
Published: September 02, 2025
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity.
Journal: Archiv der Pharmazie
Published: June 14, 2024
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells.
Journal: Archiv der Pharmazie
Published: May 31, 2024
The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.
Journal: Frontiers in oncology
Published: December 30, 2020
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer.
Journal: Frontiers in molecular biosciences
Published: November 22, 2020
Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients.
Journal: Journal of proteome research
Published: June 23, 2020
Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma.
Journal: International journal of molecular sciences
Published: April 23, 2020
Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
Journal: Mucosal immunology
Published: February 19, 2015
Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium.
Journal: Mucosal immunology
Published: August 20, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026